FindMyKOL
Clinical trialNCT03609671CompletedInterventional

Emotions Immunology and Breast Cancer

NCT03609671 is an interventional trial sponsored by Luz A. Venta, MD. As of 21 Nov 2026, it is completed. It studies Breast Cancer, Emotions and 2 more conditions. The registry lists an enrollment of 17 participants at 2 sites in 1 country. The registry lists a start date of 23 Nov 2015 and a primary completion date of 18 Mar 2019.

SponsorLuz A. Venta, MDEnrollment17Breast CancerEmotionsImmunologyTriple Negative Breast Cancer
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT03609671
FieldValue
Registry IDNCT03609671
StatusCompleted
Study typeInterventional trial
Lead sponsorLuz A. Venta, MD
Enrollment17
Registered sites2
Countries1
ConditionsBreast Cancer, Emotions, Immunology and Triple Negative Breast Cancer
Start23 Nov 2015
Primary completion18 Mar 2019
Study completion18 Mar 2019
Last update posted28 Aug 2019

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Pilot study representing a proof of concept regarding the potential for immune system enhancement with psychotherapy, resulting in improved immunological response at lumpectomy or mastectomy in patients undergoing neoadjuvant chemotherapy.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Texas, United States2 sites
  • Houston Methodist Hospital

    Houston

  • Houston Methodist Hospital Cancer Center

    Houston

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexas: 2 sitesTX2FloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT03609671

Each answer restates registry values shown on this page.

What is NCT03609671?

NCT03609671 is an interventional trial sponsored by Luz A. Venta, MD. It studies Breast Cancer, Emotions and 2 more conditions.

Who leads NCT03609671?

The registry names Luz A. Venta, MD (principal investigator, The Methodist Hospital Research Institute) as the overall official.

Where does NCT03609671 run?

The registry lists 2 sites in 1 country. Every site with a stated country is in one country: United States.

When did NCT03609671 end?

The registry lists a primary completion date of 18 Mar 2019 and a study completion date of 18 Mar 2019. The sponsor last updated the record on 28 Aug 2019.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.